Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage

Journal of Clinical Anesthesia

Volumn 24, Issue 6, 2012, Pages 508-509

  McCarthy, Grace C ^a   Allen, Terrence K ^a   Habib, Ashraf S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPROST; FRESH FROZEN PLASMA; METHYLERGOMETRINE; OXYTOCIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; CASE REPORT; CESAREAN SECTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; GESTATION PERIOD; HUMAN; LETTER; LUNG EMBOLISM; OBSTETRIC HEMORRHAGE; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; UTERINE HYPOTONIA; VAGINA BLEEDING;

ADULT; CESAREAN SECTION; FACTOR VIIA; FEMALE; HEMOSTASIS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PULMONARY EMBOLISM; RECOMBINANT PROTEINS;

EID: 84866404209     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2011.09.004     Document Type: Letter

References (18)

1. L.A. Barbour ACOG Committee on Practice Bulletins-Obstetrics ACOG practice bulletin. Thrombembolism in pregnancy Int J Gynaecol Obstet 75 2001 203 212
2. H. Salonen Ros, P. Lichtenstein, R. Bellocco, G. Petersson, and S. Cnattingius Increased risks of circulatory diseases in late pregnancy and puerperium Epidemiology 12 2001 456 460
3. H.S. Ros, P. Lichtenstein, R. Bellocco, G. Petersson, and S. Cnattingius Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am J Obstet Gynecol 186 2002 198 203
4. K.R. Nilsson, S.M. Berenholtz, E. Garrett-Mayer, T. Dorman, M.J. Klag, and P.J. Pronovost Association between venous thromboembolism and perioperative allogeneic transfusion Arch Surg 142 2007 126 133
5. N.M. Wright, M. Martin, T. Goff, J. Morgan, R. Elworthy, and S. Ghoneim Cocaine and thrombosis: a narrative systematic review of clinical and in-vivo studies Subst Abuse Treat Prev Policy 2 2007 27
6. C. Kabrhel, D. Mark Courtney, and C.A. Camargo Jr Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism Acad Emerg Med 17 2010 589 597
7. J.A. Kline, G.W. Williams, and J. Hernandez-Nino D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed Clin Chem 51 2005 825 829
8. K.A. O'Connell, J.J. Wood, R.P. Wise, J.N. Lozier, and M.M. Braun Thromboembolic adverse events after use of recombinant human coagulation factor VIIa JAMA 295 2006 293 298
9. J. Ahonen, R. Jokela, and K. Korttila An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage Acta Anaesthesiol Scand 51 2007 929 936
10. L.S. Bouma, A.C. Bolte, and H.P. van Geijn Use of recombinant activated factor VII in massive postpartum haemorrhage Eur J Obstet Gynecol Reprod Biol 137 2008 172 177
11. Z. Alfirevic, D. Elbourne, and S. Pavord Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004 Obstet Gynecol 110 2007 1270 1278
12. L.E. Phillips, C. McLintock, W. Pollock Australian and New Zealand Haemostasis Registry Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry Anesth Analg 109 2009 1908 1915
13. L. Courtois, P. Becher, and S. Miot Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use J Gynecol Obstet Biol Reprod (Paris) 36 2007 78 82
14. A. Geiger, O. Collange, J. Samin, A. Meyer, G. Freys, and T. Pottecher Efficiency and safety of recombinant activated factor VII in a case of severe postpartum hemorrhage Ann Fr Anesth Reanim 29 2010 728 731
15. M. Franchini, M. Franchi, and V. Bergamini The use of recombinant activated FVII in postpartum hemorrhage Clin Obstet Gynecol 53 2010 219 227
16. Z.H. Meng, A.S. Wolberg, D.M. Monroe 3rd, and M. Hoffman The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 55 2003 886 891
17. B.S. Kheirabadi, A.V. Delgado, and M.A. Dubick In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures J Trauma 63 2007 1079 1086
18. Y. Laurian Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 32 Suppl 1 2002 37 40